FGF23 and alcoholic liver diseases: Therefore, we suggest that CB1R-ERRγ-FGF23 signal transduction axis plays a pathological role in chronic alcoholic liver injury through regulating CYP2E1 gene expression (Fig. 6G), and FGF23 may represent a potential therapeutic target to treat alcoholic liver disease.